What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2024-02-13 compared with 2023-08-14 · 23 added, 30 removed, 10 unchanged (84% of the section changed)

Other Information

NeuroOne Medical Technologies

Certificate of Incorporation

of NeuroOne Medical Technologies Corporation (incorporated by reference to Exhibit 3.4 on the Registrant’s Current Report on

Form 8-K filed on June 29, 2017).

Certificate of Amendment

to Amended and Restated Certificate of Incorporation of NeuroOne Medical Technologies Corporation (incorporated by reference to Exhibit

3.1 on the Registrant’s Current Report on Form 8-K on March 31, 2021).

Bylaws of NeuroOne Medical

Technologies Corporation (incorporated by reference to Exhibit 3.5 on the Registrant’s Current Report on Form 8-K filed on

June 29, 2017).

Certification

of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Certification

of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Certification

of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Certification

of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

10b5-1 Trading Plans – Directors and Section 16 Officers

the three months ended December 31, 2023, none of the Company’s directors or Section 16 officers adopted or terminated any contract,

instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions

of Rule 10b5-1(c) of the Exchange Act or any “non-Rule 10b5-1 trading arrangement”.

Medical Technologies Corporation

Certificate of Incorporation of NeuroOne Medical Technologies Corporation (incorporated by reference to Exhibit 3.4 on the Registrant’s Current Report on Form 8-K filed on June 29, 2017).

Certificate of Amendment to Amended and Restated Certificate of Incorporation of NeuroOne Medical Technologies Corporation (incorporated by reference to Exhibit 3.1 on the Registrant’s Current Report on Form 8-K filed on March 31, 2021).

Bylaws of NeuroOne Medical Technologies Corporation (incorporated by reference to Exhibit 3.5 on the Registrant’s Current Report on Form 8-K filed on June 29, 2017).

Employment Offer Letter, dated as of November 10, 2023, by and between Christopher Volker and the Company (incorporated by reference to Exhibit 10.1 on the Registrant’s Current Report on Form 8-K filed on November 14, 2023).

First Amendment to 2021 Inducement Plan (incorporated by reference to Exhibit 10.2 on the Registrant’s Current Report on Form 8-K filed on November 14, 2023).

Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

XBRL Instance Document.

4 unchanged sentences

XBRL Taxonomy Extension Presentation Linkbase Document.

Cover Page Interactive

Data File (formatted as Inline XBRL and contained in Exhibit 101)

are furnished not filed.

NeuroOne Medical Technologies

Pursuant to the requirements of the Securities

Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

August 14, 2023

NeuroOne Medical Technologies Corporation

/s/ David Rosa

Chief Executive Officer

(Principal Executive Officer)

/s/ Ronald McClurg

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

Documents are furnished

Medical Technologies Corporation

to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by

the undersigned thereunto duly authorized.

Medical Technologies Corporation

Chief Executive

(Principal Executive

Ronald McClurg

Chief Financial Officer

1 unchanged sentence

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 5. Other Information